Endoscopic transsphenoidal surgery has the best remission rates and fewest postoperative complications for adults with acromegaly, according to findings from a systematic review. In an article ...

The rise in total ghrelin found to accompany some remaining cardiovascular risk markers and adiposity increase in patients with acromegaly remission after surgery could be interrelated, according to ...

Acromegaly is an endocrine disorder characterized by excessive soft tissue and bone growth, and is caused by excessive levels of growth hormone secreted by the pituitary gland. These excessive hormone ...

Acromegaly is an insidious disease that, in most cases, is a result of a pituitary adenoma that hypersecretes growth hormone (GH). The goals of therapy are to control excess GH secretion and limit, if ...

A preoperative insulinogenic index >0.5 could predict restoration of normal glucose metabolism in Japanese patients after surgical cure of acromegaly, report researchers from Tokyo. Acromegaly is ...

Treatment of Acromegaly aims to reduce excess growth hormone, relieve the pressure that the tumour is exerting on the surrounding structures and thus improve symptoms of the disease. If not treated ...

The Food and Drug Administration (FDA) has approved Palsonify ™ (paltusotine) for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an ...

Crinetics Pharmaceuticals (CRNX) just received FDA approval for PALSONIFY, a once-daily oral treatment for adults with acromegaly who have not responded to surgery, or for those for whom surgery is ...

Adam Rainer's life is a unique medical case. Born in Austria in 1899, he was initially a dwarf. Later, he experienced rapid growth due to a pituitary tumor. Doctors diagnosed him with acromegaly.